High Dose Methotrexate
Showing 1 - 25 of >10,000
Evaluation of High Dose Methotrexate Toxicity
Not yet recruiting
- Methotrexate Toxicity
- blood methotrexate level and Cystatin C level
- (no location specified)
Nov 7, 2023
Patients With Cancer Treated With High-dose Methotrexate
Recruiting
- Acute Kidney Injury
- Drug Toxicity
- High-dose methotrexate
- Glucarpidase
-
Marseille, France
- +4 more
Jun 9, 2023
High-Dose Methotrexate Clearance in Diffuse Large B-Cell
Recruiting
- Central Nervous System Lymphoma
- Diffuse Large B-Cell Lymphoma
- Non-Interventional Study
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 8, 2023
Primary CNS Lymphoma Trial in Paris (Glucarpidase, Methotrexate (MTX))
Recruiting
- Primary Central Nervous System Lymphoma
- Glucarpidase
- Methotrexate (MTX)
-
Paris, FranceHôpital Pitié-Salpêtrière
Oct 24, 2022
T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,
Not yet recruiting
- T-cell Lymphoblastic Lymphoma
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
- Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
-
Shanghai, Shanghai, China
- +1 more
Dec 27, 2022
Osteosarcoma Trial in Toronto (High Dose Methotrexate)
Completed
- Osteosarcoma
- High Dose Methotrexate
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Oct 27, 2021
Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)
Recruiting
- Secondary Central Nervous System Lymphoma
- Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
-
Beijing, Beijing, ChinaPeking University Cancer Hospital & Institute
May 25, 2022
Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)
Active, not recruiting
- Primary Central Nervous System Lymphoma
- Rituximab, Methotrexate, Temozolomide
-
Paris, FranceGroupe Hospitalier Pitie Salpetriere
Feb 10, 2022
Metastatic Breast Cancer, Leptomeningeal Disease Trial in Baltimore, Saint Louis, Winston-Salem (High-dose Methotrexate (8
Recruiting
- Metastatic Breast Cancer
- Leptomeningeal Disease
- High-dose Methotrexate (8 gm/m2; HD-MTX)
-
Baltimore, Maryland
- +2 more
May 5, 2022
CNS Lymphoma Trial in Berlin (Voraxaze Injectable Product)
Recruiting
- CNS Lymphoma
- Voraxaze Injectable Product
-
Berlin, GermanyCharité Campus Benjamin Franklin (CBF)
Jul 18, 2022
Graft-versus-host-disease, Relapse Trial in Calgary (Treatment Arm - high dose ATG, Control Arm - standard of care)
Recruiting
- Graft-versus-host-disease
- Relapse
- Treatment Arm - high dose ATG
- Control Arm - standard of care
-
Calgary, Alberta, CanadaTom Baker Cancer Centre
Oct 14, 2022
Lymphoma, Acute Lymphoblastic Leukemia, Pediatric Cancer Trial in Richmond (Intravenous fluids)
Recruiting
- Lymphoma
- +4 more
- Intravenous fluids
-
Richmond, VirginiaVirginia Commonwealth University/ Massey Cancer Center/ Children
Aug 25, 2022
CNS Lymphoma Trial in Seongnam-si (lenalidomide)
Recruiting
- Central Nervous System Lymphoma
-
Seongnam-si, Please Select, Korea, Republic ofSeoul National University Bundang Hospital
Feb 18, 2022
ALL Trial in Chicago (IOHEXOL)
Completed
- ALL
-
Chicago, IllinoisAnn & Robert H. Lurie Children's Hosptial of Chicago
Jul 26, 2021
Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)
CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,
Active, not recruiting
- CNS Lymphoma
- +2 more
- Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
-
Basking Ridge, New Jersey
- +2 more
Jan 27, 2023
Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an
Recruiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- +2 more
- dasatinib plus consolidation chemotherapy with vincristine and prednisone
- dasatinib plus consolidation chemotherapy with high-dose methotrexate and cytarabine
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Sep 29, 2021
Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)
Recruiting
- Primary CNS Lymphoma
- Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
-
Moscow, Russian FederationNathional Medical Research Center for Hematology
Jun 16, 2022
Primary CNS Lymphoma Trial in Zhengzhou (Rituximab, Lenalidomide, Methotrexate)
Recruiting
- Primary Central Nervous System Lymphoma
- Rituximab
- +3 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 30, 2021
Diffuse Large B Cell Lymphoma, CNS Lymphoma Trial in Beijing (Methotrexate)
Recruiting
- Diffuse Large B Cell Lymphoma
- Central Nervous System Lymphoma
-
Beijing, Beijing, ChinaPeking union medical college hospital
Sep 21, 2021
CNS Lymphoma Trial (chidamide combined with rituximab and high-dose methotrexate)
Not yet recruiting
- Central Nervous System Lymphoma
- chidamide combined with rituximab and high-dose methotrexate
- (no location specified)
Aug 14, 2020
Primary CNS Lymphoma Trial in Shanghai (Orelabrutinib, Rituximab, Methotrexate (MTX))
Recruiting
- Primary Central Nervous System Lymphoma
- Orelabrutinib
- +3 more
-
Shanghai, Shanghai, ChinaDepartment of Hematology, Huashan Hospital, Fudan University
Jul 26, 2022
Mantle Cell Lymphoma Trial in Houston (Bortezomib, Cyclophosphamide, Cytarabine)
Completed
- Mantle Cell Lymphoma
- Bortezomib
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2022
Osteosarcoma Trial in Worldwide (Calcium Folinate, [6R] 5,10-methylenetetrahydrofolate (arfolitixorin))
Completed
- Osteosarcoma
- Calcium Folinate
- [6R] 5,10-methylenetetrahydrofolate (arfolitixorin)
-
Brno, Czechia
- +4 more
Sep 7, 2020